Continuous intravenous flumazenil infusion in a patient with chlordiazepoxide toxicity and hepatic encephalopathy

M. Al-Halawani, Parijat Sen, Yazan Abdeen, Hamid Shaaban, Allan J. Klukowicz, Richard A. Miller

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Flumazenil, a benzodiazepine receptor antagonist, is the drug of choice for the diagnosis and treatment of benzodiazepine overdose. We are presenting a patient with chronic alcoholism and alcoholic liver disease, who came with alcohol withdrawal symptoms and treated chlordiazepoxide. Subsequently he developed a prolonged change in mental status that required treatment for benzodiazepine overdose and hepatic encephalopathy with flumazenil infusion for 28 days.

Original languageEnglish
Pages (from-to)58-60
Number of pages3
JournalJournal of Emergencies, Trauma and Shock
Volume8
Issue number1
DOIs
StatePublished - Jan 1 2015

Keywords

  • Chlordiazepoxide
  • flumazenil
  • hepatic encephalopathy

ASJC Scopus subject areas

  • Emergency Medicine

Fingerprint

Dive into the research topics of 'Continuous intravenous flumazenil infusion in a patient with chlordiazepoxide toxicity and hepatic encephalopathy'. Together they form a unique fingerprint.

Cite this